Intrinsic Value

Is BBN undervalued or overvalued?

See the intrinsic value estimate for Bellevue Group AG and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

BBN Intrinsic Value
LOCKED
Unlock
Today vs. history

BBN looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with BBN’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor BBN
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price CHf6.7
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to BBN

Fundamental Analysis

What Bellevue Group Does

Financial Services Financials

Bellevue Group AG is a Swiss asset manager that runs investment products for institutional and private clients. Its core business is managing money through funds and mandates, with a strong focus on healthcare and other specialized equity strategies. It earns most of its money from management fees and performance-related fees tied to the assets it oversees.

Headquarters
Switzerland CH
Employees
73
IPO date
Jan 15, 2007
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Bellevue Group AG

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one BBN stock?

The intrinsic value for Bellevue Group AG (BBN) under the Base Case is hidden CHF.

Is BBN stock undervalued or overvalued?

Compared with the current market price of 6.7 CHF, the stock appears hidden.

Back to Top